“Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease,” by Michael F. Egan, James Kost, Tiffini Voss, Yuki Mukai, Paul S. Aisen, Jeffrey L. Cummings, Pierre N. Tariot, Bruno Vellas, Christopher H. van Dyck, Merce Boada, Ying Zhang, Wen Li, Christine Furtek, Erin Mahoney, Lyn Harper Mozley, Yi Mo, Cyrille Sur, and David Michelson (Vol. 380, No. 15, April 11, 2019, p. 1408-1420).
April 12, 2019
CAAR – New England Journal of Medicine Article Abstract – April 12, 2019
Comments Off on CAAR – New England Journal of Medicine Article Abstract – April 12, 2019
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
